Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Brain --- Brain Diseases, Metabolic --- Metabolism --- Disorders --- Brain Diseases, Metabolic. --- Cerveau --- Métabolisme --- Maladies --- Acquired Metabolic Diseases, Brain --- Acquired Metabolic Diseases, Nervous System --- Acquired Metabolic Encephalopathies --- Brain Diseases, Metabolic, Acquired --- Brain Disorders, Metabolic --- Brain Disorders, Metabolic, Acquired --- Brain Syndrome, Metabolic --- Brain Syndrome, Metabolic, Acquired --- CNS Metabolic Disorders --- CNS Metabolic Disorders, Acquired --- Encephalopathy, Metabolic, Acquired --- Metabolic Brain Diseases --- Metabolic Brain Diseases, Acquired --- Metabolic Brain Syndrome --- Metabolic Brain Syndrome, Acquired --- Metabolic Brain Syndromes --- Metabolic Brain Syndromes, Acquired --- Metabolic Diseases, Acquired, Nervous System --- Metabolic Disorder, Central Nervous System, Acquired --- Metabolic Disorders, CNS --- Metabolic Disorders, CNS, Acquired --- Metabolic Disorders, Central Nervous System --- Metabolic Encephalopathies --- Nervous System Acquired Metabolic Diseases --- Central Nervous System Metabolic Disorders --- Encephalopathies, Metabolic --- Metabolic Disorders, Brain --- Acquired Metabolic Encephalopathy --- Brain Disease, Metabolic --- Brain Disorder, Metabolic --- Brain Metabolic Disorder --- Brain Metabolic Disorders --- CNS Metabolic Disorder --- Encephalopathies, Acquired Metabolic --- Encephalopathy, Acquired Metabolic --- Encephalopathy, Metabolic --- Metabolic Brain Disease --- Metabolic Brain Disorder --- Metabolic Brain Disorders --- Metabolic Disorder, Brain --- Metabolic Disorder, CNS --- Metabolic Encephalopathies, Acquired --- Metabolic Encephalopathy --- Metabolic Encephalopathy, Acquired --- Cerebrum --- Mind --- Central nervous system --- Head

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Nonlinear Control for Blood Glucose Regulation of Diabetic Patients: An LMI-Based Approach exposes readers to the various existing mathematical models that define the dynamics of glucose-insulin for Type 1 diabetes patients. After providing insights into the mathematical model of patients, the authors discuss the need and emergence of new control techniques that can lead to further development of an artificial pancreas. The book presents various nonlinear control techniques to address the challenges that Type 1 diabetic patients face in maintaining their blood glucose level in the safe range (70-180 mg/dl). The closed-loop solution provided by the artificial pancreas depends mainly on the effectiveness of the control algorithm, which acts as the brain of the system. APS control algorithms require a mathematical model of the gluco-regulatory system of the T1D patients for their design. Since the gluco-regulatory system is inherently nonlinear and largely affected by external disturbances and parametric uncertainty, developing an accurate model is very difficult.

Blood Glucose --- Pancreas, Artificial --- Glucose Metabolism Disorders --- Glucose Metabolic Disorder --- Glucose Metabolic Disorders --- Glucose Metabolism Disorder --- Disorder, Glucose Metabolic --- Disorder, Glucose Metabolism --- Disorders, Glucose Metabolic --- Disorders, Glucose Metabolism --- Metabolic Disorder, Glucose --- Metabolic Disorders, Glucose --- Metabolism Disorder, Glucose --- Metabolism Disorders, Glucose --- Artificial Pancreas --- Blood Sugar --- Glucose, Blood --- Sugar, Blood --- Glucose --- Glycemic Index --- blood --- Blood glucose monitoring --- Nonlinear control theory. --- Technological innovations. --- Control theory --- Nonlinear theories --- Blood glucose self-monitoring --- Blood sugar monitoring --- Monitoring, Blood glucose --- Blood glucose --- Patient monitoring --- Analysis --- Diabetes. --- Artificial pancreas. --- Diabetes Mellitus --- Models, Theoretical --- Mathematical models.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Lipidoses. --- Nervous system --- Cerebral Sclerosis, Diffuse. --- Lipoidosis. --- Metabolism --- Disorders. --- Diffuse Cerebral Sclerosis of Schilder. --- Brain Diseases, Metabolic. --- Lipid Metabolism, Inborn Errors. --- Lipidoses --- -Organs (Anatomy) --- Neurosciences --- Lipid storage diseases --- Lipid storage disorders --- Lipidosis --- Lipoidosis --- Lipids --- Lipid Metabolism, Inborn Error --- Acquired Metabolic Diseases, Brain --- Acquired Metabolic Diseases, Nervous System --- Acquired Metabolic Encephalopathies --- Brain Diseases, Metabolic, Acquired --- Brain Disorders, Metabolic --- Brain Disorders, Metabolic, Acquired --- Brain Syndrome, Metabolic --- Brain Syndrome, Metabolic, Acquired --- CNS Metabolic Disorders --- CNS Metabolic Disorders, Acquired --- Encephalopathy, Metabolic, Acquired --- Metabolic Brain Diseases --- Metabolic Brain Diseases, Acquired --- Metabolic Brain Syndrome --- Metabolic Brain Syndrome, Acquired --- Metabolic Brain Syndromes --- Metabolic Brain Syndromes, Acquired --- Metabolic Diseases, Acquired, Nervous System --- Metabolic Disorder, Central Nervous System, Acquired --- Metabolic Disorders, CNS --- Metabolic Disorders, CNS, Acquired --- Metabolic Disorders, Central Nervous System --- Metabolic Encephalopathies --- Nervous System Acquired Metabolic Diseases --- Central Nervous System Metabolic Disorders --- Encephalopathies, Metabolic --- Metabolic Disorders, Brain --- Acquired Metabolic Encephalopathy --- Brain Disease, Metabolic --- Brain Disorder, Metabolic --- Brain Metabolic Disorder --- Brain Metabolic Disorders --- CNS Metabolic Disorder --- Encephalopathies, Acquired Metabolic --- Encephalopathy, Acquired Metabolic --- Encephalopathy, Metabolic --- Metabolic Brain Disease --- Metabolic Brain Disorder --- Metabolic Brain Disorders --- Metabolic Disorder, Brain --- Metabolic Disorder, CNS --- Metabolic Encephalopathies, Acquired --- Metabolic Encephalopathy --- Metabolic Encephalopathy, Acquired --- Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis --- Alpers Disease --- Alpers Progressive Infantile Poliodystrophy --- Alpers' Disease --- Alpers' Syndrome --- Alpers-Huttenlocher Syndrome --- Balo's Concentric Sclerosis --- Encephalitis Periaxialis Concentrica --- Encephalitis Periaxialis Diffusa --- Neuronal Degeneration Of Childhood With Liver Disease, Progressive --- Progressive Neuronal Degeneration of Childhood with Liver Disease --- Progressive Sclerosing Poliodystrophy --- Schilder's Disease --- Sudanophilic Cerebral Sclerosis --- Alpers Syndrome --- Balo Concentric Sclerosis --- Cerebral Sclerosis, Diffuse --- Encephalitis Periaxialis --- Myelinoclastic Diffuse Sclerosis --- Poliodystrophia Cerebri --- Schilder Disease --- Alper Disease --- Alper Syndrome --- Alper's Disease --- Alper's Syndrome --- Alpers Huttenlocher Syndrome --- Concentric Sclerosis, Balo --- Concentric Sclerosis, Balo's --- Diffuse Cerebral Scleroses --- Diffuse Cerebral Sclerosis --- Diffuse Scleroses, Myelinoclastic --- Diffuse Sclerosis, Myelinoclastic --- Disease, Alpers' --- Disease, Schilder --- Disease, Schilder's --- Myelinoclastic Diffuse Scleroses --- Progressive Sclerosing Poliodystrophies --- Schilders Disease --- Scleroses, Balo's Concentric --- Scleroses, Myelinoclastic Diffuse --- Sclerosis, Diffuse Cerebral --- Sclerosis, Myelinoclastic Diffuse --- Syndrome, Alpers --- Syndrome, Alpers-Huttenlocher --- -Disorders --- Disorders --- -Metabolism --- Brain Diseases, Metabolic --- Diffuse Cerebral Sclerosis of Schilder --- Lipid Metabolism, Inborn Errors --- Organs (Anatomy) --- Metabolism&delete&

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The use of medical devices (e.g., catheters, implants, and probes) is a common and essential part of medical care for both diagnostic and therapeutic purposes. However, these devices quite frequently lead to the incidence of infections due to the colonization of their abiotic surfaces by biofilm-growing microorganisms, which are progressively resistant to antimicrobial therapies. Several methods based on anti-infective biomaterials that repel microbes have been developed to combat device-related infections. Among these strategies, surface coating with antibiotics (e.g., beta-lactams), natural compounds (e.g., polyphenols), or inorganic elements (e.g., silver and copper nanoparticles) has been widely recognized as exhibiting broad-spectrum bactericidal or bacteriostatic activity. So, in order to achieve a better therapeutic response, it is crucial to understand how these infections are different from others. This will allow us to find new biomaterials characterized by antifouling coatings with repellent properties or low adhesion towards microorganisms, or antimicrobial coatings that are capable of killing microbes approaching the surface, improving biomaterial functionalization strategies and supporting tissues’ bio-integration.

Candida --- biofilms --- diabetes --- medical devices --- candidiasis --- metabolic disorder --- hyperglycemia --- infection --- Candida glabrata --- candidemia --- echinocandins --- resistance --- micafungin --- caspofungin --- in vivo --- titanium dioxide --- nanotubes --- autoclaving --- titanium alloy --- biocompatibility --- wettability --- mechanical properties --- silver nanoparticles --- titanium dioxide nanotubes --- silver ions release --- biointegration --- antimicrobial activity --- polyethylene terephthalate --- PET --- electrospinning --- nanofibers --- antimicrobial agents --- Taguchi method --- antimicrobial efficiency --- cold atmospheric-pressure plasma jet (CAPJ) --- Escherichia coli --- DNA double-strand breaks --- scanning electron microscopy --- Ti6Al4V implants --- anodization process --- XPS --- genotoxicity assessment --- anti-inflammatory properties --- oral biofilm --- infection control --- Streptococcus mutans --- Candida spp. --- natural compounds --- antimicrobial resistance --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Explores the underlying mechanisms of insulin resistance and the metabolic syndrome as they relate to coronary heart disease, heart failure, hypertension, and secondary cardiovascular problems. Combines theory with practice in meaningful applications that detail how to manage your at-risk patients. Provides the help needed to formulate rational therapeutic interventions that will effectively prevent or mitigate the manifestations of the conditions that have emerged as key precursors to cardiovascular disease.

Cardiovascular Diseases. --- Insulin Resistance. --- Metabolism --- Cardiovascular system --- Hyperinsulinism --- Diseases --- Drug Resistance --- Glucose Metabolism Disorders --- Pharmacological Phenomena --- Metabolic Diseases --- Physiological Phenomena --- Phenomena and Processes --- Nutritional and Metabolic Diseases --- Insulin Resistance --- Cardiovascular Diseases --- Medicine --- Health & Biological Sciences --- Disorders. --- Diseases. --- Cardiovascular Disease --- Disease, Cardiovascular --- Diseases, Cardiovascular --- Cardiology --- Insulin Sensitivity --- Resistance, Insulin --- Sensitivity, Insulin --- Donohue Syndrome --- Nutritional Physiological Phenomena --- Physiological Concepts --- Physiological Phenomenon --- Physiological Process --- Physiological Processes --- Concept, Physiological --- Concepts, Physiological --- Phenomena, Physiological --- Phenomenas, Physiological --- Phenomenon, Physiological --- Physiological Concept --- Process, Physiological --- Processes, Physiological --- Diseases, Metabolic --- Thesaurismosis --- Disease, Metabolic --- Metabolic Disease --- Thesaurismoses --- Pharmacologic Phenomena --- Pharmacologic Phenomenon --- Pharmacologic Process --- Pharmacological Concepts --- Pharmacological Phenomenon --- Pharmacologic Processes --- Pharmacological Processes --- Concept, Pharmacological --- Concepts, Pharmacological --- Pharmacological Concept --- Phenomena, Pharmacologic --- Phenomena, Pharmacological --- Phenomenon, Pharmacologic --- Phenomenon, Pharmacological --- Process, Pharmacologic --- Processes, Pharmacologic --- Processes, Pharmacological --- Glucose Metabolic Disorder --- Glucose Metabolic Disorders --- Glucose Metabolism Disorder --- Disorder, Glucose Metabolic --- Disorder, Glucose Metabolism --- Disorders, Glucose Metabolic --- Disorders, Glucose Metabolism --- Metabolic Disorder, Glucose --- Metabolic Disorders, Glucose --- Metabolism Disorder, Glucose --- Metabolism Disorders, Glucose --- Resistance, Drug --- Pharmacogenetics --- Compensatory Hyperinsulinemia --- Endogenous Hyperinsulinism --- Exogenous Hyperinsulinism --- Hyperinsulinemia --- Hyperinsulinemia, Compensatory --- Hyperinsulinism, Endogenous --- Hyperinsulinism, Exogenous --- Insulin --- Pancreatic Diseases --- Cardiovascular diseases --- Disorders of metabolism --- Metabolic diseases --- Metabolic disorders --- Metabolism, Disorders of --- Adverse Cardiac Event --- Cardiac Events --- Major Adverse Cardiac Events --- Adverse Cardiac Events --- Cardiac Event --- Cardiac Event, Adverse --- Cardiac Events, Adverse --- Event, Cardiac